Introduction In the spring of 2025, eleven EU health ministers described Europe’s dependence on Chinese medicines as the weak point in Europe’s defense. The warning was accurate but largely ignored. For twenty of fifty-six active pharmaceutical ingredients (APIs) that German regulators classify as essential to supply, enough of the world’s production sits in China that […]